Wellbutrin
$ 66,00 – $ 627,00Price range: $ 66,00 through $ 627,00
Womenra
$ 50,00 – $ 300,00Price range: $ 50,00 through $ 300,00
Wellbutrin SR
$ 62,00 – $ 299,00Price range: $ 62,00 through $ 299,00
Wellbutrin SR is a trusted antidepressant medication specifically designed to help individuals manage the symptoms of major depressive disorder. This sustained-release formula works by balancing key neurotransmitters in the brain, such as norepinephrine and dopamine, to enhance overall mood. By providing a steady delivery of its active ingredient, the medication helps maintain consistent therapeutic levels throughout the day. It is an effective option for those seeking to regain interest in daily activities and improve their overall energy and focus. Wellbutrin SR offers a reliable and well-established approach to supporting long-term mental health and emotional stability.
Active substance: Bupropion
SKU:
Wellbutrin SR
Categories: AntiDepressants, Quit Smoking, Respiratory Tract
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Wellbutrin SR belongs to the aminoketone class of antidepressant medications, distinguishing itself pharmacologically from selective serotonin reuptake inhibitors and tricyclic agents. Prescribed under strict federal regulations as a prescription-only therapy in the United States, it is primarily authorized by the FDA for the management of major depressive disorder.
The sustained-release formulation is engineered to release bupropion hydrochloride gradually over time, maintaining therapeutic plasma levels while limiting peak concentration spikes. Understanding its clinical profile, administration protocols, and safety considerations is essential for achieving optimal therapeutic outcomes under proper medical supervision.
| Drug name | Wellbutrin SR |
| Active ingredient (INN) | Bupropion hydrochloride |
| Therapeutic class | Aminoketone antidepressant |
| Dosage form | Sustained-release oral tablet |
| Route of administration | Oral |
| Primary purpose | Major depressive disorder |
| Prescription status | Prescription (Rx only) |
| Storage | Store at 20°C to 25°C (68°F to 77°F) |
How the drug works
The precise mechanism through which Wellbutrin SR exerts its therapeutic antidepressant effect in humans is not fully elucidated, but it is known to act via neurochemical pathways distinct from most other conventional antidepressants. Bupropion hydrochloride is a relatively weak inhibitor of the neuronal reuptake of norepinephrine and dopamine. It does not inhibit monoamine oxidase to any meaningful degree and exhibits negligible activity on the reuptake of serotonin. Furthermore, bupropion displays minimal affinity for histamine, alpha-adrenergic, or muscarinic acetylcholine receptors, which accounts for its lower propensity to induce sedation, orthostatic hypotension, or anticholinergic adverse effects compared to tricyclic antidepressants.
What it’s used for
The official FDA-approved primary indication for Wellbutrin SR is the treatment of major depressive disorder in adult patients. In clinical trials, sustained-release bupropion demonstrated efficacy in alleviating core depressive symptoms, including depressed mood, anhedonia, and fatigue. Off-label, healthcare prescribers may sometimes consider bupropion formulations for conditions such as attention-deficit/hyperactivity disorder (ADHD), smoking cessation support, or management of antidepressant-induced sexual dysfunction. However, these off-label applications fall outside the primary FDA-approved prescribing label for the SR brand formulation and must be evaluated on an individual risk-benefit basis by a licensed prescriber.
Dosing schedule
The administration of Wellbutrin SR must strictly follow personalized medical guidance to minimize seizure risks. For adult major depressive disorder, initial dosing typically begins at 150 mg administered once daily in the morning. If well tolerated, the dose may be increased after three days to the target adult maintenance dose of 300 mg per day, given as 150 mg twice daily. A single dose of Wellbutrin SR should never exceed 150 mg, and successive doses must be spaced at least 8 hours apart to prevent excessive peak plasma concentrations. Tablets must be swallowed whole with or without food and should never be crushed, chewed, or divided, as altering the sustained-release matrix accelerates drug absorption and elevates adverse reaction risks.
What happens in the body
Following oral administration of Wellbutrin SR, bupropion is rapidly absorbed from the gastrointestinal tract, reaching median peak plasma concentrations (Cmax) within approximately 3 hours. The absolute bioavailability of bupropion in humans has not been definitively established due to safety constraints regarding intravenous administration, but extent of absorption is substantial. Bupropion undergoes extensive hepatic metabolism via the CYP2B6 isoenzyme pathway to form its primary active metabolite, hydroxybupropion, as well as the erythrohydrobupropion and threohydrobupropion metabolites via non-CYP pathways. The mean elimination half-life of bupropion is approximately 21 hours (with a range of 11 to 35 hours), while active metabolites exhibit extended half-lives ranging from 20 to 37 hours. Renal elimination accounts for roughly 87% of the dose excreted as metabolites.
First days of treatment
When initiating therapy with Wellbutrin SR, therapeutic antidepressant benefits are rarely instantaneous. Patients often observe initial changes in physical energy or sleep patterns within the first one to two weeks, whereas clinical improvements in overall mood and interest in daily activities typically require four to six weeks of continuous therapy. During the initial days, mild transitory side effects such as dry mouth, insomnia, or mild restlessness may occur as the central nervous system adapts to altered catecholamine levels. Patients are strongly advised not to alter their prescribed regimen abruptly during this initial titration period without consulting their treating healthcare provider.
Compatibility with other medicines
Wellbutrin SR possesses a clinically significant drug interaction profile that requires thorough screening before starting treatment. Concomitant administration with monoamine oxidase inhibitors (MAOIs) is strictly contraindicated due to the risk of severe hypertensive reactions; at least 14 days must elapse between discontinuing an MAOI and starting bupropion. Because bupropion is metabolized primarily by CYP2B6, co-administration with strong CYP2B6 inhibitors (such as ticlopidine or clopidogrel) can elevate bupropion plasma levels, necessitating dose adjustment. Conversely, CYP2B6 inducers (such as ritonavir, lopinavir, carbamazepine, or efavirenz) can significantly decrease bupropion exposure. Additionally, caution is warranted when co-administering drugs that lower the seizure threshold, such as antipsychotics, corticosteroids, systemic dopamine agonists, or other antidepressants.
Adverse reactions
Clinical trial data indicate that Wellbutrin SR is generally tolerated, but it carries a distinct adverse effect profile. Common nervous system and psychiatric side effects include agitation, dry mouth, insomnia, headache, dizziness, tremor, and diaphoresis. Gastrointestinal complaints such as nausea, constipation, abdominal pain, and appetite suppression leading to weight loss are frequently documented. Cardiovascular manifestations may include mild tachycardia, palpitations, or transient elevations in blood pressure. Dose-dependent seizures represent a serious potential adverse effect, occurring at a rate of approximately 0.1% at total daily doses up to 300 mg. Patients experiencing severe neuropsychiatric symptoms or signs of systemic hypersensitivity should discontinue therapy and report to healthcare professionals immediately.
What to avoid while taking it
Wellbutrin SR may be taken with or without food, as food intake does not clinically alter the overall bioavailability or sustained-release absorption kinetics of bupropion hydrochloride. However, consumption of alcohol during treatment should be minimized or completely avoided. Excessive alcohol intake, acute alcohol intoxication, or abrupt cessation of heavy alcohol consumption while taking bupropion can significantly lower the seizure threshold and precipitate convulsive episodes. Furthermore, patients undergoing abrupt withdrawal from benzodiazepines, barbiturates, or sedatives must not take Wellbutrin SR due to a marked increase in seizure susceptibility.
Red flags
Certain clinical signs require immediate emergency medical care during therapy with Wellbutrin SR. Patients, families, and caregivers must remain alert to signs of acute hypersensitivity, such as swelling of the face, lips, tongue, or throat, severe skin rash, hives, or difficulty breathing. Immediate intervention is required if a patient experiences a generalized seizure or loss of consciousness. Furthermore, prompt medical evaluation is critical if there is a sudden emergence of severe chest pain, irregular heart rhythms, acute confusion, visual hallucinations, or sudden worsening of depression characterized by suicidal ideation or self-harm thoughts.
Missed dose
If a dose of Wellbutrin SR is missed, the patient should skip the missed dose entirely and resume treatment at the next regularly scheduled dosing interval. Patients should never double up on doses or take two sustained-release tablets at the same time to compensate for a missed dose, as doubling the dose sharply increases plasma drug concentrations and heightens the risk of triggering a seizure. Maintaining a minimum spacing of 8 hours between consecutive doses remains a crucial safety guideline throughout treatment.
Important precautions
Wellbutrin SR carries an FDA Boxed Warning regarding the increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults aged 18 to 24 during initial antidepressant treatment. Prescribers must monitor patients closely for behavioral changes, worsening depression, or emergent suicidality. Wellbutrin SR is contraindicated in patients with a current or prior diagnosis of seizure disorders, bulimia, or anorexia nervosa due to an elevated incidence of seizures in these populations. For patients with hepatic impairment, dosage reduction or decreased frequency is necessary due to reduced drug clearance. Use during pregnancy (FDA Category C) and lactation requires a careful assessment of maternal benefit versus potential fetal or infant risk, as bupropion and its metabolites pass into human breast milk.
Common questions
What should I do if Wellbutrin SR causes insomnia?
Insomnia is a recognized adverse effect associated with the activating properties of bupropion. Taking the morning dose as early as possible and ensuring the evening dose is taken early in the late afternoon (while maintaining an 8-hour spacing) often reduces sleep disruption. If insomnia persists, consult your prescribing physician for dosage timing adjustments.
Can Wellbutrin SR be taken alongside other antidepressants?
Combining Wellbutrin SR with other antidepressants requires direct medical supervision. While bupropion is sometimes prescribed adjunctively with selective serotonin reuptake inhibitors (SSRIs) to offset sexual dysfunction or enhance efficacy, combining it with drugs that lower the seizure threshold or with MAOIs is strictly hazardous. Never initiate or modify dual antidepressant therapy independently.
How long does it take for Wellbutrin SR to be completely eliminated from the body?
The parent compound bupropion has an elimination half-life of approximately 21 hours, meaning major clearance occurs within 4 to 5 days. However, its active metabolites (such as hydroxybupropion) have longer elimination half-lives of up to 37 hours, meaning complete physiological clearance of all active compounds can take up to a week after treatment discontinuation.
Is it safe to drive or operate machinery after starting Wellbutrin SR?
Wellbutrin SR can affect central nervous system performance, causing dizziness, lightheadedness, or altered concentration in some individuals. Until you understand how the medication affects your cognitive and motor abilities, avoid driving, operating heavy machinery, or engaging in hazardous tasks requiring complete mental alertness.
Why must Wellbutrin SR tablets be swallowed whole without crushing?
Wellbutrin SR tablets utilize a specialized sustained-release matrix designed to release bupropion gradually. Crushing, chewing, breaking, or dissolving the tablet destroys this controlled-release mechanism, resulting in rapid drug absorption, abnormally high peak plasma concentrations, and a significantly heightened risk of dose-dependent seizures.
In accordance with FDA requirements.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
150mg |
|---|---|
| Package |
60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Abilify
$ 45,00 – $ 413,00Price range: $ 45,00 through $ 413,00
Active substance: Aripiprazole
More Details
This product has multiple variants. The options may be chosen on the product page
Asendin
$ 41,00 – $ 369,00Price range: $ 41,00 through $ 369,00
Active substance: Amoxapine
More Details
This product has multiple variants. The options may be chosen on the product page
Clozaril
$ 45,00 – $ 129,00Price range: $ 45,00 through $ 129,00
Active substance: Clozapine
More Details
This product has multiple variants. The options may be chosen on the product page
Cymbalta
$ 46,00 – $ 561,00Price range: $ 46,00 through $ 561,00
Active substance: Duloxetine
More Details
This product has multiple variants. The options may be chosen on the product page
Desyrel
$ 41,00 – $ 206,00Price range: $ 41,00 through $ 206,00
Active substance: Trazodone
More Details
This product has multiple variants. The options may be chosen on the product page
Elavil
$ 39,00 – $ 222,00Price range: $ 39,00 through $ 222,00
Active substance: amitriptyline
More Details
This product has multiple variants. The options may be chosen on the product page
Geodon
$ 46,00 – $ 418,00Price range: $ 46,00 through $ 418,00
Active substance: Ziprasidone
More Details
This product has multiple variants. The options may be chosen on the product page
Paroxetine
$ 44,00 – $ 321,00Price range: $ 44,00 through $ 321,00
Active substance: paroxetine
More Details
This product has multiple variants. The options may be chosen on the product page
